Pharsight

Taro Pharms patents expiration

1. Pliaglis patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10751305 TARO PHARMS Solid-forming topical formulations for pain control
Jan, 2031

(7 years from now)

US10350180 TARO PHARMS Solid-forming local anesthetic formulations for pain control
Jan, 2031

(7 years from now)

US10603293 TARO PHARMS Solid-forming local anesthetic formulations for pain control
Jan, 2031

(7 years from now)

Drugs and Companies using LIDOCAINE; TETRACAINE ingredient

Market Authorisation Date: 29 June, 2006

Treatment: NA

Dosage: CREAM;TOPICAL

More Information on Dosage

PLIAGLIS family patents

Family Patents

2. Topicort patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8715624 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
May, 2026

(2 years from now)

US8277780 TARO PHARMS Stable liquid desoximethasone compositions with reduced oxidized impurity
Sep, 2028

(4 years from now)

Drugs and Companies using DESOXIMETASONE ingredient

Market Authorisation Date: 11 April, 2013

Treatment: Treatment of plaque psoriasis in patients 18 years of age or older

Dosage: SPRAY;TOPICAL

How can I launch a generic of TOPICORT before it's drug patent expiration?
More Information on Dosage

TOPICORT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic